3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Recurrent Platinum Resistant Ovarian Cancer
1
Rectal Neoplasms
1
Neoplasm Metastasis
1
Colorectal Neoplasms
1
Carcinoma
1
Adenoviridae Infections
1
Interventions
Carboplatin
9
pembrolizumab
8
Paclitaxel
8
Cisplatin
8
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Gemcitabine
5
fludarabine
4
Specimen Handling
4
Pemetrexed
4
Nivolumab
4
Cyclophosphamide
4
trebananib
3
osimertinib
3
liposomal doxorubicin
3
Radiotherapy
3
Interleukin-2
3
Fluorouracil
3
Docetaxel
3
DNA
3
volociximab
2
poly ICLC
2
lenvatinib
2
fludarabine phosphate
2
Sorafenib
2
Radiosurgery
2
Midazolam
2
Capecitabine
2
Biopsy
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Carcinoma
×
enadenotucirev
×
Clear all
NCT02636036
2021-11-09
SPICE
Akamis Bio
Phase 1
Completed
51 enrolled